Correlation between narrow band imaging and nonneoplastic gastric pathology: a pilot feasibility trial - 23/08/11
Kansas City, Missouri, USA
Abstract |
Background |
A novel narrow band imaging (NBI) system is able to visualize the mucosal and vascular network in the GI tract.
Objective |
The aim of the current study was to test the feasibility of NBI to predict gastric histologic diagnosis.
Design |
A pilot feasibility study.
Setting |
Veterans Affairs Medical Center.
Patients |
Forty-seven patients undergoing upper endoscopy for various indications were prospectively enrolled.
Methods |
The gastric body and antrum were systematically examined by NBI before targeted biopsies. Images were graded according to the mucosal (ridge/villous and circular) and vascular patterns and correlated with histologic findings in a blinded manner.
Main Outcome Measurements |
Final histologic diagnosis based on updated Sydney classification system.
Results |
Overall, 25 patients (53.1%) had a normal biopsy specimen, 13 (27.6%) had non–Helicobacter pylori gastritis, 4 (8.5%) had H pylori gastritis, and 5 (10.6%) had intestinal metaplasia. The sensitivity, specificity, and positive predictive value of a regular mucosal and vascular pattern for the diagnosis of normal mucosa/mild gastritis were 89%, 78%, and 94%, respectively. The sensitivity and specificity of an irregular pattern with decreased density of vessels for the diagnosis of H pylori were 75% and 88%, and that of the ridge/villous pattern for the diagnosis of intestinal metaplasia were 80% and 100%, respectively.
Limitation |
The small number of patients with H pylori and intestinal metaplasia was the main limitation.
Conclusions |
This is the first U.S. study of NBI for gastric lesions. NBI may help predict in vivo histologic diagnosis of gastric pathologic conditions with a good degree of accuracy. Future larger studies are needed.
Le texte complet de cet article est disponible en PDF.Abbreviations : NBI, RGB, SECN
Plan
Vol 67 - N° 2
P. 210-216 - février 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
